A number of disclosures made last week support an immediate end to the Pfizer COVID vaccines. On Tuesday, March 1, the U.S. FDA’s Center for Biologics Evaluation and Research permitted access to the 55,000 page set of documents which Pfizer submitted to the FDA from its clinical trials in support of a COVID-19 vaccine emergency use authorization.
